title: Does the presence of a mutation at position V179 impact on virological outcome in patients receiving antiretroviral medication?
authors.affiliation: Imperial College London, London, United Kingdom. Electronic address: jasper.vink12@imperial.ac.uk.
authors.forename: Jasper
authors.initials: J
authors.lastname: Vink
authors.affiliation: Imperial College London, London, United Kingdom; Chelsea and Westminster Hospital London, London, United Kingdom.
authors.forename: Katie
authors.initials: K
authors.lastname: McFaul
authors.affiliation: Chelsea and Westminster Hospital London, London, United Kingdom.
authors.forename: Daniel
authors.initials: D
authors.lastname: Bradshaw
authors.affiliation: Imperial College London, London, United Kingdom; Chelsea and Westminster Hospital London, London, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male
chemical_list: D019380:Anti-HIV Agents